Boji Medical TechnologyLtd Past Earnings Performance
Past criteria checks 2/6
Boji Medical TechnologyLtd has been growing earnings at an average annual rate of 26.4%, while the Life Sciences industry saw earnings growing at 21.5% annually. Revenues have been growing at an average rate of 23.6% per year. Boji Medical TechnologyLtd's return on equity is 3.3%, and it has net margins of 4.7%.
Key information
26.4%
Earnings growth rate
23.3%
EPS growth rate
| Life Sciences Industry Growth | 26.8% |
| Revenue growth rate | 23.6% |
| Return on equity | 3.3% |
| Net Margin | 4.7% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Boji Medical TechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 620 | 29 | 113 | 56 |
| 31 Dec 23 | 556 | 24 | 109 | 55 |
| 30 Sep 23 | 504 | 29 | 117 | 51 |
| 30 Jun 23 | 481 | 30 | 112 | 48 |
| 31 Mar 23 | 453 | 27 | 108 | 45 |
| 31 Dec 22 | 424 | 28 | 104 | 44 |
| 30 Sep 22 | 388 | 27 | 98 | 37 |
| 30 Jun 22 | 379 | 40 | 95 | 34 |
| 31 Mar 22 | 343 | 44 | 87 | 30 |
| 01 Jan 22 | 324 | 39 | 80 | 28 |
| 30 Sep 21 | 298 | 31 | 74 | 30 |
| 30 Jun 21 | 271 | 19 | 71 | 28 |
| 31 Mar 21 | 295 | 30 | 67 | 28 |
| 31 Dec 20 | 260 | 17 | 67 | 26 |
| 30 Sep 20 | 259 | 20 | 64 | 23 |
| 30 Jun 20 | 241 | 16 | 62 | 22 |
| 31 Mar 20 | 209 | -1 | 66 | 21 |
| 31 Dec 19 | 224 | 7 | 67 | 18 |
| 30 Sep 19 | 201 | 7 | 67 | 16 |
| 30 Jun 19 | 189 | 5 | 61 | 15 |
| 31 Mar 19 | 177 | 4 | 57 | 13 |
| 31 Dec 18 | 172 | 7 | 54 | 13 |
| 30 Sep 18 | 155 | -16 | 60 | 13 |
| 30 Jun 18 | 153 | -19 | 54 | 16 |
| 31 Mar 18 | 152 | -16 | 52 | 13 |
| 31 Dec 17 | 131 | -24 | 51 | 10 |
| 30 Sep 17 | 121 | -3 | 45 | 7 |
| 30 Jun 17 | 103 | 4 | 50 | 0 |
| 31 Mar 17 | 74 | -1 | 47 | 0 |
| 31 Dec 16 | 72 | 2 | 45 | 0 |
| 30 Sep 16 | 81 | 11 | 40 | 0 |
| 30 Jun 16 | 88 | 12 | 40 | 0 |
| 31 Mar 16 | 111 | 22 | 38 | 0 |
| 31 Dec 15 | 127 | 26 | 37 | 0 |
| 30 Sep 15 | 150 | 39 | 30 | 0 |
| 30 Jun 15 | 153 | 39 | 29 | 0 |
| 31 Mar 15 | 148 | 39 | 28 | 0 |
| 31 Dec 14 | 144 | 38 | 27 | 0 |
| 31 Dec 13 | 136 | 35 | 22 | 0 |
Quality Earnings: 300404 has a large one-off loss of CN¥7.1M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 300404's current net profit margins (4.7%) are lower than last year (5.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300404's earnings have grown significantly by 26.4% per year over the past 5 years.
Accelerating Growth: 300404's earnings growth over the past year (8.2%) is below its 5-year average (26.4% per year).
Earnings vs Industry: 300404 earnings growth over the past year (8.2%) exceeded the Life Sciences industry 0.9%.
Return on Equity
High ROE: 300404's Return on Equity (3.3%) is considered low.